Skip to Content

Aptamer Sciences Inc Ordinary Shares 291650

Morningstar Rating
KRW 3,405.00 +55.00 (1.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

291650 is trading at a 45% discount.
Price
KRW 3,512.43
Fair Value
KRW 9,613.70
Uncertainty
Extreme
1-Star Price
KRW 76,524.42
5-Star Price
KRW 151.98
Economic Moat
Cqbx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 291650 is a good fit for your portfolio.

News

Trading Information

Previous Close Price
Day Range
KRW 3,315.003,405.00
52-Week Range
Bid/Ask
KRW 3,380.00 / KRW 3,405.00
Market Cap
KRW 57.82 Bil
Volume/Avg
12,714 / 203,601

Key Statistics

Price/Earnings (Normalized)
Price/Sales
233.91
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aptamer Sciences Inc is a research and development based bio venture company. The company is focused on the Aptamer Technology Platform for the development of innovative therapeutic and diagnostic platforms. It develops and facilitates drug development and other diagnostic products.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
41

Comparables

Valuation

Metric
291650
228760
314930
Price/Earnings (Normalized)
Price/Book Value
4.054.236.03
Price/Sales
233.91140.6667.05
Price/Cash Flow
Price/Earnings
291650
228760
314930

Financial Strength

Metric
291650
228760
314930
Quick Ratio
1.5817.7633.73
Current Ratio
1.6418.0635.00
Interest Coverage
−9.53−5.57−8,694.04
Quick Ratio
291650
228760
314930

Profitability

Metric
291650
228760
314930
Return on Assets (Normalized)
−31.70%−5.18%−2.51%
Return on Equity (Normalized)
−59.14%−6.67%−2.56%
Return on Invested Capital (Normalized)
−40.39%−7.80%−3.88%
Return on Assets
291650
228760
314930
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRVcvrqxcvnxGcvf$570.1 Bil
VRTX
Vertex Pharmaceuticals IncDcbdjwtHfjdm$107.8 Bil
REGN
Regeneron Pharmaceuticals IncFylnpyxrCjnvdxp$105.6 Bil
MRNA
Moderna IncSxwbtgqBpvwt$40.8 Bil
ARGX
argenx SE ADRMzcrctnRhhnl$23.7 Bil
BNTX
BioNTech SE ADRJzthgcbhDdby$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncQxysrlkHkmnc$19.4 Bil
BMRN
Biomarin Pharmaceutical IncNhxsrhxKxffxw$16.7 Bil
RPRX
Royalty Pharma PLC Class AYvsnzqdnwStnjxq$13.6 Bil
INCY
Incyte CorpXbjsvblhMhcsxkd$12.8 Bil

Sponsor Center